| 8 Einträge |
| Neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): 5-year analysis of a randomised, double-blind, placebo-controlled, phase 3 trial. | |
| Autoren | Martin M, Holmes FA, Ejlertsen B, Delaloge S, Moy B, Iwata H, von Minckwitz G, Chia SKL, Mansi J, Barrios CH, Gnant M, Tomašević Z, Denduluri N, Šeparović R, Gokmen E, Bashford A, Ruiz Borrego M, Kim SB, Jakobsen EH, Ciceniene A, Inoue K, Overkamp F, Heijns JB, Armstrong AC, Link JS, Joy AA, Bryce R, Wong A, Moran S, Yao B, Xu F, Auerbach A, Buyse M, Chan A |
| Erscheinungsdaten | The Lancet. Oncology. 2017 Nov 13. pii: S1470-2045(17)30717-9. doi: 10.1016/S1470-2045(17)30717-9 |
| Publikations ID | PMID: 29146401 |
| Combining the differentiating effect of panobinostat with the apoptotic effect of arsenic trioxide leads to significant survival benefit in a model of t(8;21) acute myeloid leukemia. | |
| Autoren | Salmon JM, Bots M, Vidacs E, Stanley KL, Atadja P, Zuber J, Johnstone RW |
| Erscheinungsdaten | Clinical epigenetics. 2015 Jan 22. doi: 10.1186/s13148-014-0034-4. pii: 34. pmc: PMC4308003 |
| Publikations ID | PMID: 25628765 |
| Interconversion between Tumorigenic and Differentiated States in Acute Myeloid Leukemia. | |
| Autoren | McKenzie MD, Ghisi M, Oxley EP, Ngo S, Cimmino L, Esnault C, Liu R, Salmon JM, Bell CC, Ahmed N, Erlichster M, Witkowski MT, Liu GJ, Chopin M, Dakic A, Simankowicz E, Pomilio G, Vu T, Krsmanovic P, Su S, Tian L, Baldwin TM, Zalcenstein DA, DiRago L, Wang S, Metcalf D, Johnstone RW, Croker BA, Lancaster GI, Murphy AJ, Naik SH, Nutt SL, Pospisil V, Schroeder T, Wall M, Dawson MA, Wei AH, de Thé H, Ritchie ME, Zuber J, Dickins RA |
| Erscheinungsdaten | Cell stem cell. pii: S1934-5909(19)30299-1. doi: 10.1016/j.stem.2019.07.001 |
| Publikations ID | PMID: 31374198 |
| Chimeric Antigen Receptor-T Cell Therapy: Practical Considerations for Implementation in Europe. | |
| Autoren | Buechner J, Kersten MJ, Fuchs M, Salmon F, Jäger U |
| Erscheinungsdaten | HemaSphere. 2018 Feb 2. doi: 10.1097/HS9.0000000000000018. pii: HemaSphere-2017-0031. pmc: PMC6745952 |
| Publikations ID | PMID: 31723747 |
| No improvement of survival with reduced- versus high-intensity conditioning for allogeneic stem cell transplants in Ewing tumor patients. | |
| Autoren | Thiel U, Wawer A, Wolf P, Badoglio M, Santucci A, Klingebiel T, Basu O, Borkhardt A, Laws HJ, Kodera Y, Yoshimi A, Peters C, Ladenstein R, Pession A, Prete A, Urban EC, Schwinger W, Bordigoni P, Salmon A, Diaz MA, Afanasyev B, Lisukov I, Morozova E, Toren A, Bielorai B, Korsakas J, Fagioli F, Caselli D, Ehninger G, Gruhn B, Dirksen U, Abdel-Rahman F, Aglietta M, Mastrodicasa E, Torrent M, Corradini P, Demeocq F, Dini G, Dreger P, Eyrich M, Gozdzik J, Guilhot F, Holler E, Koscielniak E, Messina C, Nachbaur D, Sabbatini R, Oldani E, Ottinger H, Ozsahin H, Schots R, Siena S, Stein J, Sufliarska S, Unal A, Ussowicz M, Schneider P, Woessmann W, Jürgens H, Bregni M, Burdach S |
| Erscheinungsdaten | Annals of oncology : official journal of the European Society for Medical Oncology. 2011 Jan 18. pii: S0923-7534(19)38449-2. doi: 10.1093/annonc/mdq703 |
| Publikations ID | PMID: 21245159 |
| Correction to: Combining the differentiating effect of panobinostat with the apoptotic effect of arsenic trioxide leads to significant survival benefit in a model of t(8;21) acute myeloid leukemia. | |
| Autoren | Salmon JM, Bots M, Vidacs E, Stanley KL, Atadja P, Zuber J, Johnstone RW |
| Erscheinungsdaten | Clinical epigenetics. 2020 Nov 18. doi: 10.1186/s13148-020-00964-9. pii: 10.1186/s13148-020-00964-9 |
| Publikations ID | PMID: 33208184 |
| Standardization of molecular monitoring of CML: results and recommendations from the European treatment and outcome study. | |
| Autoren | White HE, Salmon M, Albano F, Andersen CSA, Balabanov S, Balatzenko G, Barbany G, Cayuela JM, Cerveira N, Cochaux P, Colomer D, Coriu D, Diamond J, Dietz C, Dulucq S, Engvall M, Franke GN, Gineikiene-Valentine E, Gniot M, Gómez-Casares MT, Gottardi E, Hayden C, Hayette S, Hedblom A, Ilea A, Izzo B, Jiménez-Velasco A, Jurcek T, Kairisto V, Langabeer SE, Lion T, Meggyesi N, Mešanović S, Mihok L, Mitterbauer-Hohendanner G, Moeckel S, Naumann N, Nibourel O, Oppliger Leibundgut E, Panayiotidis P, Podgornik H, Pott C, Rapado I, Rose SJ, Schäfer V, Touloumenidou T, Veigaard C, Venniker-Punt B, Venturi C, Vigneri P, Vorkinn I, Wilkinson E, Zadro R, Zawada M, Zizkova H, Müller MC, Saussele S, Ernst T, Machova Polakova K, Hochhaus A, Cross NCP |
| Erscheinungsdaten | Leukemia. 2022 May 25. doi: 10.1038/s41375-022-01607-z. pii: 10.1038/s41375-022-01607-z |
| Publikations ID | PMID: 35614319 |
| Impact of BCR::ABL1 transcript type on RT-qPCR amplification performance and molecular response to therapy. | |
| Autoren | Salmon M, White HE, Zizkova H, Gottschalk A, Motlova E, Cerveira N, Colomer D, Coriu D, Franke GN, Gottardi E, Izzo B, Jurcek T, Lion T, Schäfer V, Venturi C, Vigneri P, Zawada M, Zuna J, Hovorkova L, Koblihova J, Klamova H, Markova MS, Srbova D, Benesova A, Polivkova V, Zackova D, Mayer J, Roeder I, Glauche I, Ernst T, Hochhaus A, Polakova KM, Cross NCP |
| Erscheinungsdaten | Leukemia. 2022 Jun 8. doi: 10.1038/s41375-022-01612-2. pii: 10.1038/s41375-022-01612-2 |
| Publikations ID | PMID: 35676453 |